Journal of Cardiothoracic and Vascular AnesthesiaRemimazolam besylate is a novel, short-acting benzodiazepine with a more favorable hemodynamic and respiratory profile than traditional anesthetics and may be suitable for procedural sedation. The objective of this study was to assess the safety, feasibility, and clinical advantages of remimazolam compared to propofol for procedural sedation during ...
d'Andria Ursoleo, Jacopo +7 more
openaire +5 more sources
Effect of remimazolam besylate versus propofol on haemodynamic profiles in patients undergoing thyroid surgery with recurrent laryngeal nerve monitoring: a protocol for a randomised controlled trial [PDF]
BMJ OpenIntroduction Thyroid surgery with intraoperative nerve monitoring under total intravenous anaesthesia often requires deeper sedation due to limitations or lack of neuromuscular blocking agents, usually resulting in haemodynamic instability.
Wei Wei +8 more
doaj +2 more sources
Etomidate Combined with Propofol versus Remimazolam for Sedation in Elderly Patients During Gastrointestinal Endoscopy: A Randomized Prospective Clinical Trial [PDF]
Drug Design, Development and TherapyQin Zhang,1 Rui Zhao,1 Yaqing Wu,2 Liming Zhang,1 Yi Feng2 1Endoscopy Center, Peking University People’s Hospital, Beijing, People’s Republic of China; 2Department of Anesthesiology, Peking University People’s Hospital, Beijing, People’s Republic of ...
Zhang Q, Zhao R, Wu Y, Zhang L, Feng Y
doaj +1 more source
Remimazolam besylate versus propofol for deep sedation in critically ill patients: a randomized pilot study. [PDF]
Crit Care, 2023 Abstract Objective To compare the efficacy and safety of remimazolam besylate and propofol for deep sedation in critically ill patients. Methods In this single-center, prospective, randomized, controlled pilot study, patients in the intensive care unit (ICU) requiring deep ...
Tang Y +10 more
europepmc +3 more sources
Combined Use of Remimazolam and Ciprofol Reduces Hypoxemia and Shortens Recovery Time During Sedated Gastrointestinal Endoscopy [PDF]
Drug Design, Development and TherapyHai-Ding Zou,1,2 Cong Luo,1,2 Zhao-Lan Hu,1,2 Pei Zhou,1,2 Ru-Yi Luo1,2 1Department of Anesthesiology, The Second Xiangya Hospital, Central South University, Changsha, People’s Republic of China; 2Anesthesia Medical Research Center, Central South ...
Zou HD, Luo C, Hu ZL, Zhou P, Luo RY
doaj +1 more source
Up-down determination of the 90% effective dose (ED90) of remimazolam besylate for anesthesia induction [PDF]
Annals of Palliative Medicine, 2022 Remimazolam besylate for injection is a novel benzodiazepine. Reasonable selection and proper application of anesthetics is critical for patients. This study aims to determine the 90% effective dose (ED90) of remimazolam besylate for anesthesia induction in patients undergoing painless colonoscopy.A dose-response study was carried out in 112 patients ...
Zhixia, Lu +4 more
openaire +2 more sources
Incompatibility of remimazolam besylate with Ringer's acetate infusion resulting in total occlusion of an intravenous catheter. [PDF]
BMJ Case Rep, 2021 Remimazolam besylate is an ultra-short-acting benzodiazepine derivative recently approved in Japan for general anaesthesia. However, less attention has been paid to the compatibility of remimazolam with infusion solutions, and the mechanism underlying the incompatibility remains unknown.
Matsuo M, Okada K, Onuki Y, Yamazaki M.
europepmc +3 more sources
Efficacy and safety of remimazolam besylate in patients receiving mechanical ventilation: A randomized phase Ⅱa trial. [PDF]
J Intensive MedYang X +9 more
europepmc +2 more sources
Perioperative Nerve Blockade Reduces Acute Postoperative Pain after Orthognathic Surgery
Pain Research and Management, Volume 2023, Issue 1, 2023., 2023 Background. The role of perioperative pain management is not only to reduce acute postoperative pain (POP) but also to prevent chronic POP. It would be important to know the usefulness of nerve blockade for perioperative management. However, it has not been extensively studied in orofacial surgery.
Yuka Oono +4 more
wiley +1 more source
Comparison of the recovery time of remimazolam besylate and propofol for gastrointestinal endoscopy sedation in elderly patients. [PDF]
Int J Med SciBackground: Recovery time is a crucial factor in ensuring the safety and effectiveness of both patients and endoscopy centers. Propofol is often preferred due to its fast onset and minimal side effects. Remimazolam is a new intravenous sedative agent, characterized by its rapid onset of action, quick recovery and organ-independent metabolism ...
Chen HY +6 more
europepmc +3 more sources